Patents by Inventor Shlomit Wizel

Shlomit Wizel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymorphic forms of nateglinide
    Publication number: 20080319075
    Abstract: Provides are crystalline forms of nateglinide, labeled Forms A, C, D, F, G, I, J, K, L, M, N, O, P, Q, T, U, V, Y, ?, ?, ?, ?, ?, ?, ? and ?, processes for their preparation and processes for preparation of other crystalline forms of nateglinide. Also provided are their pharmaceutical formulations and methods of administration.
    Type: Application
    Filed: April 23, 2008
    Publication date: December 25, 2008
    Inventors: Ronit Yahalomi, Evgeny Shapiro, Ben-Zion Dolitzky, Igal Gozlan, Boaz Gome, Shlomit Wizel
  • Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
    Patent number: 7468444
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: December 23, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam, Revital Lifshitz, Shlomit Wizel
  • Novel crystalline forms of gatifloxacin
    Publication number: 20080269488
    Abstract: Provided are two novel crystalline forms of gatifloxacin, denominated form O and form V, and methods for their preparation.
    Type: Application
    Filed: July 1, 2008
    Publication date: October 30, 2008
    Inventors: Valerie Niddam-Hildesheim, Shlomit Wizel, Greta Sterimbaum, Ehud Amir
  • Crystalline forms of gatifloxacin
    Patent number: 7423153
    Abstract: Provided are novel crystalline forms of gatifloxacin denominated forms A, B, C, D, E1, F, G, H, I, and J, and methods for their preparation. Also provided are methods for making known crystalline forms of gatifloxacin, in particular forms omega and T2RP.
    Type: Grant
    Filed: May 12, 2003
    Date of Patent: September 9, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Valerie Niddam-Hildesheim, Shlomit Wizel, Greta Sterimbaum, Ehud Amir
  • Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel process for preparing other forms
    Publication number: 20080214650
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Application
    Filed: October 23, 2007
    Publication date: September 4, 2008
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam, Revital Lifshitz, Shlomit Wizel
  • Polymorphic forms of nateglinide
    Patent number: 7420084
    Abstract: Provides are crystalline forms of nateglinide, labeled Forms A, C, D, F, G, I, J, K, L, M, N, 0, P, Q, T, U, V, Y, ?, ?, ?, ?, ?, ?, ? and ?, processes for their preparation and processes for preparation of other crystalline forms of nateglinide. Also provided are their pharmaceutical formulations and methods of administration.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: September 2, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Ronit Yahalomi, Evgeny Shapiro, Ben-Zion Dolitzky, Yigael Gozlan, Boaz Gome, Shlomit Wizel
  • Crystalline forms of gatifloxacin
    Patent number: 7411067
    Abstract: Provided are two novel crystalline forms of gatifloxacin, denominated form O and form V, and methods for their preparation.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: August 12, 2008
    Assignee: Teva Pharmaceutical Industries Ltd
    Inventors: Valerie Niddam-Hildesheim, Shlomit Wizel, Greta Sterimbaum, Ehud Amir
  • Crystalline rosuvastatin calcium
    Publication number: 20080176878
    Abstract: Provided is a crystalline form of rosuvastatin calcium characterized by X-ray powder diffraction peaks at about 4.7, 19.4 and 22.3° 2 theta±0.2° 2 theta and processes for the preparation thereof.
    Type: Application
    Filed: September 18, 2007
    Publication date: July 24, 2008
    Inventors: Shlomit Wizel, Valerie Niddam-Hildesheim, Shalom Shabat
  • Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
    Publication number: 20080167498
    Abstract: The present invention relates to novel essentially pure venlafaxine and the process of preparation thereof. The present invention also relates to novel solvate forms of venlafaxine hydrochloride and the process of preparation thereof. Furthermore, the present invention provides a novel process for preparing venlafaxine hydrochloride from venlafaxine; the process comprises the steps of: i) preparing a mixture of venlafaxine with acetone; and ii) exposing the mixture in gaseous hydrochloric acid.
    Type: Application
    Filed: March 13, 2008
    Publication date: July 10, 2008
    Inventors: Ben-Zion Dolitzky, Judith Aronhime, Shlomit Wizel, Gennady A. Nisnevich
  • Crystalline forms of gatifloxacin
    Patent number: 7396839
    Abstract: Provided are novel crystalline forms of gatifloxacin, denominated forms L, M, P, Q, S, and T1, and methods for making them. Also provided are methods of transforming the novel crystalline forms of gatifloxacin of the present invention to other crystalline forms of gatifloxacin.
    Type: Grant
    Filed: August 6, 2003
    Date of Patent: July 8, 2008
    Assignee: Teva Pharmaceuticals USA, Inc.
    Inventors: Valerie Niddam-Hildesheim, Shlomit Wizel, Greta Sterimbaum
  • Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
    Publication number: 20080132707
    Abstract: Crystalline pantoprazole sodium Forms II, IV, V, VI, VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVII, XVIII, XIX and XX; pantoprazole sodium solvates containing water, acetone, butanol, methylethylketone, dimethylcarbonate, propanol and 2-methylpropanol; and amorphous pantoprazole sodium are disclosed.
    Type: Application
    Filed: July 27, 2007
    Publication date: June 5, 2008
    Inventors: Nina Finkelstein, Barnaba Krochmal, Shlomit Wizel, Viviana Braude
  • Amorphous cinacalcet hydrochloride and preparation thereof
    Patent number: 7368606
    Abstract: Provided is amorphous cinacalcet hydrochloride, processes for the preparation thereof, and pharmaceutical compositions therewith.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: May 6, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Michael Pinchasov, Shlomit Wizel, Sharon Avhar-Maydan
  • Amorphous and Crystalline Forms of Losartan Potassium and Process For Their Preparation
    Publication number: 20080096945
    Abstract: This invention relates to novel amorphous losartan potassium, novel losartan potassium in a crystalline form that is a hydrate, novel crystalline losartan potassium Form IV and solvates thereof, novel crystalline losartan potassium Form V and solvates thereof, to processes for their preparation, to compositions containing them and to their use in medicine. This invention further relates to a novel process for preparing crystalline losartan potassium Form I and Form II.
    Type: Application
    Filed: December 21, 2007
    Publication date: April 24, 2008
    Inventors: Ben DOLITZKY, Shlomit WIZEL, Gennady NISNEVICH, Igor RUKHMAN, Julia KAFTANOV
  • Polymorphic forms of nateglinide
    Patent number: 7358390
    Abstract: Provides are crystalline forms of nateglinide, labeled Forms A, C, D, F, G, I, J, K, L, M, N, O, P, Q, T, U, V, Y, ?, ?, ?, ?, ?, ?, ? and ?, processes for their preparation and processes for preparation of other crystalline forms of nateglinide. Also provided are their pharmaceutical formulations and methods of administration.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: April 15, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Ronit Yahalomi, Evgeny Shapiro, Ben-Zion Dolitzky, Igal Gozlan, Boaz Gome, Shlomit Wizel
  • Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
    Patent number: 7342120
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: March 11, 2008
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam, Revital Lifshitz, Shlomit Wizel
  • Amorphous and crystalline forms of losartan potassium and process for their preparation
    Patent number: 7332612
    Abstract: This invention relates to novel amorphous losartan potassium, novel losartan potassium in a crystalline form that is a hydrate, novel crystalline losartan potassium Form IV and solvates thereof, novel crystalline losartan potassium Form V and solvates thereof, to processes for their preparation, to compositions containing them and to their use in medicine. This invention further relates to a novel process for preparing crystalline losartan potassium Form I and Form II.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: February 19, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Ben Zion Dolitzky, Shlomit Wizel, Gennady Nisnevich, Igor Rukhman, Julia Kaftanov
  • POLYMORPHS OF ESZOPICLONE MALATE
    Publication number: 20080027223
    Abstract: The present invention provides crystalline Eszopiclone malate form II, crystalline Eszopiclone form V, processes from preparing the crystalline Eszopiclone malate form II or V, pharmaceutical compositions comprising the crystalline Eszopiclone malate form II or V and methods of treating insomnia comprising administering the crystalline Eszopiclone malate form II or V.
    Type: Application
    Filed: March 23, 2007
    Publication date: January 31, 2008
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Alex Mainfeld, Shlomit Wizel, Marioara Mendelovici, Anita Liberman, Tamas Koltai
  • Crystalline forms of gatifloxacin and processes for preparation
    Patent number: 7301024
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: November 27, 2007
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterimbaum, Shlomit Wizel
  • Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
    Publication number: 20070265456
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin. Also provided is atorvastatin hemi-calcium Form VIII that is stable against the formation of atorvastatin hemi-calcium is atorvastatin calcium epoxy dihydroxy (AED).
    Type: Application
    Filed: May 9, 2006
    Publication date: November 15, 2007
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam-Hildesheim, Shlomit Wizel, Revital Lifshitz-Liron, Michael Pinchasov
  • Process for the preparation of cefdinir
    Publication number: 20070244315
    Abstract: The invention relates to processes for preparing cefdinir via its potassium and cesium salts.
    Type: Application
    Filed: October 31, 2006
    Publication date: October 18, 2007
    Inventors: Vinod Kansal, Dhirenkumar Mistry, Saurabh Pandey, Rakesh Patel, Shlomit Wizel